bivalirudin
bivalirudin is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand names including bivalirudin, Bivalirudin. Available dosage forms: injection, powder, lyophilized, for suspension, injection, powder, lyophilized, for solution, powder.
Drug details
- Generic Name
- bivalirudin
- Brand Names
- bivalirudin, Bivalirudin
- Application Number
- ANDA213078
- Sponsor
- Slate Run Pharmaceuticals, LLC
- NDC Codes
- 10
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, POWDER
- Routes
- INTRAVENOUS
- Active Ingredients
- BIVALIRUDIN
Indications and Usage
1 INDICATIONS AND USAGE Bivalirudin for Injection is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Bivalirudin for Injection is a direct thrombin inhibitor indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia (HIT) or heparin-induced thrombocytopenia and thrombosis syndrome (HITTS) ( 1 )